Novartis Ag (NVS) Intangibles (2009 - 2026)
Novartis Ag (NVS) reported Intangibles of $11.8 billion for Q3 2026, down 59.4% from $29.04 billion a year earlier and down 72.0% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Novartis Ag posted Intangibles of $29.41 billion, up 9.3% from FY2024.
- Intangibles has a five-year compound annual growth rate of -4.4% (FY2020 to FY2025).
- By year, Intangibles came in at $26.92 billion in FY2024 (+0.1%), $26.88 billion in FY2023 (-15.1%), $31.64 billion in FY2022 (-7.4%) and $34.18 billion in FY2021 (-7.1%).
- The Q3 2026 figure ranks as the lowest quarterly Intangibles since Q1 2022.
- Year over year, Intangibles gained in seven of the last eight quarters, with growth averaging 6.8%.
- The high point for year-over-year Intangibles in five years was Q1 2022 (growth of 632.5%); the low point was Q3 2026 (a decline of 59.4%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $42.07 billion (Q2 2026), $40.21 billion (Q1 2026) and $29.41 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,263.50 Bn | 1,237.12 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 655.05 Bn | 574.91 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 512.00 Bn | 485.11 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 368.57 Bn | 368.57 Bn | - | - |
| 5 | Novartis Ag | 313.61 Bn | 286.85 Bn | - | 11.80 Bn |
| 6 | Astrazeneca | 290.22 Bn | 263.91 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 252.64 Bn | 208.04 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 212.62 Bn | 212.62 Bn | - | 13.42 Bn |
| 9 | Pfizer | 175.96 Bn | 122.60 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Vertex Pharmaceuticals | 140.19 Bn | 112.20 Bn | 2.84 Bn | 412.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.80 Bn |
| Jun 30, 2026 | 42.07 Bn |
| Mar 31, 2026 | 40.21 Bn |
| Dec 31, 2025 | 29.41 Bn |
| Sep 30, 2025 | 29.04 Bn |
| Jun 30, 2025 | 29.24 Bn |
| Mar 31, 2025 | 27.48 Bn |
| Dec 31, 2024 | 26.92 Bn |
| Sep 30, 2024 | 27.90 Bn |
| Jun 30, 2024 | 27.78 Bn |
| Mar 31, 2024 | 26.27 Bn |
| Dec 31, 2023 | 26.88 Bn |
| Sep 30, 2023 | 26.42 Bn |
| Jun 30, 2023 | 28.00 Bn |
| Dec 31, 2022 | 31.64 Bn |
| Sep 30, 2022 | 31.89 Bn |
| Jun 30, 2022 | 33.37 Bn |
| Mar 31, 2022 | 901.00 Mn |
| Dec 31, 2021 | 34.18 Bn |
| Sep 30, 2021 | 33.95 Bn |
API Access
Novartis Ag Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();